Impact Biomedical (IBO) Shares Outstanding (2022 - 2026)

Impact Biomedical (IBO) has reported Shares Outstanding (Entity) for 5 consecutive years, with $107.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 784.84% year-over-year to $107.8 million; the trailing twelve-month figure through Jun 2026 stood at $107.8 million (up 784.84% YoY), and the FY2025 full-year result was $31.6 million, up 174.26% from the prior year.
• Shares Outstanding (Entity) was little changed at $107.8 million in Q2 2026 per IBO's latest filing, from $107.8 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $3.9 billion in Q2 2022 and bottomed at $10.0 million in Q2 2024.
• Historically, Shares Outstanding (Entity) has averaged $271.6 million across 5 years, with a median of $60.2 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) sank 98.18% in 2023, then jumped 792.16% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $70.5 million in 2022, then slipped by 14.54% to $60.2 million in 2023, then sank by 80.91% to $11.5 million in 2024, then surged by 174.26% to $31.6 million in 2025, then soared by 241.74% to $107.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $107.8 million, $107.8 million, and $31.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.